Extra-adrenal Paraganglioma: Clinical Trials

1 trial for Extra-adrenal Paraganglioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Extra-adrenal Paraganglioma: new trials by email Literature Review of Extra-adrenal Paraganglioma trials Research Report on Extra-adrenal Paraganglioma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
vorinostat, temozolomide, diagnostic laboratory biomarker analysis - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma
Phase 1CompletedNational Cancer Institute (NCI)272010-02-012013-05-03

Narrower conditions

Astrocytoma (1)  ·  Choroid Plexus Neoplasms (1)  ·  Familial ependymoma (1)  ·  Medulloblastoma (1)  ·  Oligodendroglioma (1)  ·  Optic Nerve Glioma (1)  ·  Paraganglioma, Extra-Adrenal (1)  ·  Rhabdoid Tumor (1)  ·  Spinal Cord Neoplasms (1)

Broader conditions

Brain Diseases (1)  ·  Brain Neoplasms (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Cerebral Ventricle Neoplasms (1)  ·  Cranial Nerve Diseases (1)  ·  Cranial Nerve Neoplasms (1)  ·  Eye Diseases (1)  ·  Glioma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Complex and Mixed (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Temozolomide (1)  ·  Vorinostat (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Trent Hummel (1)

Results publications

PMID 23554030

NIH funding

U01CA097452 (1)